Proceedings of Asociación Aragonesa de Ginecología y Obstetricia (AGOA) 2021 congress

IF 0.5 4区 医学 Q4 OBSTETRICS & GYNECOLOGY
L. B. Mainar
{"title":"Proceedings of Asociación Aragonesa de Ginecología y Obstetricia (AGOA) 2021 congress","authors":"L. B. Mainar","doi":"10.31083/J.EJGO.2021.03.2021","DOIUrl":null,"url":null,"abstract":"Marta Lamarca Ballestero*, Leticia Álvarez Sarrado, Javier Navarro Sierra, Yasmina José Gutiérrez, Isabel Negredo Quintana, Miguel Angel Ruiz Conde Department of Gynecology, Miguel Servet University Hospital, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain. * m.lamarca@yahoo.es Objectives: To describe the clinical findings, treatment, and outcome of borderline ovarian tumors in 32 premenopausal patients admitted to the Miguel Servet University Hospital over a 17-year period. Methods: Thirty-two premenopausal patients diagnosed and treated from 2003 to 2020 for borderline ovarian tumors were retrospectively evaluated. Results: The 32 borderline included 12 serous, 19 mucinous, and 1 endometrioid tumors, 2 of them were of stage more than I. The average age of the patients was 34.5 years (14–45), 22 were symptomatic, pain being the most frequent symptom (68.8%). 8 patients were operated on primarily by laparoscopy and 24 by laparotomy. In the laparoscopy group, median tumor diameter was smaller (7.5 versus 14.7 cm, p = 0.019) and surgeries were less extensive, without hysterectomy, as compared to the laparotomy group. There were 21 fertility-sparing surgeries, 7 patients attempted a subsequent pregnancy and in 6 cases a pregnancy with a healthy child was obtained (2 using assisted reproductive techniques). During the 7–108 months follow-up time, there were 3 relapses: 2 borderline tumors (treated surgically and desease free) and 1 carcinoma treated with surgery and chemotherapy that ended in death due to cancer. Discussion: In our study, only 6.25% of the borderline tumors were of stage more than I, whereas other studies report a higher proportion of more advanced stages (7.5–18.5%). As borderline ovarian tumors more often arise in young women, in whom malignancy is less common and who wish to preserve their fertility, their initial surgery is often laparoscopy. Conclusions: Borderline ovarian tumors have an excellent prognosis. Good results are provided in young patients wishing to preserve fertility.","PeriodicalId":11903,"journal":{"name":"European journal of gynaecological oncology","volume":"42 1","pages":"605-609"},"PeriodicalIF":0.5000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of gynaecological oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/J.EJGO.2021.03.2021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Marta Lamarca Ballestero*, Leticia Álvarez Sarrado, Javier Navarro Sierra, Yasmina José Gutiérrez, Isabel Negredo Quintana, Miguel Angel Ruiz Conde Department of Gynecology, Miguel Servet University Hospital, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain. * m.lamarca@yahoo.es Objectives: To describe the clinical findings, treatment, and outcome of borderline ovarian tumors in 32 premenopausal patients admitted to the Miguel Servet University Hospital over a 17-year period. Methods: Thirty-two premenopausal patients diagnosed and treated from 2003 to 2020 for borderline ovarian tumors were retrospectively evaluated. Results: The 32 borderline included 12 serous, 19 mucinous, and 1 endometrioid tumors, 2 of them were of stage more than I. The average age of the patients was 34.5 years (14–45), 22 were symptomatic, pain being the most frequent symptom (68.8%). 8 patients were operated on primarily by laparoscopy and 24 by laparotomy. In the laparoscopy group, median tumor diameter was smaller (7.5 versus 14.7 cm, p = 0.019) and surgeries were less extensive, without hysterectomy, as compared to the laparotomy group. There were 21 fertility-sparing surgeries, 7 patients attempted a subsequent pregnancy and in 6 cases a pregnancy with a healthy child was obtained (2 using assisted reproductive techniques). During the 7–108 months follow-up time, there were 3 relapses: 2 borderline tumors (treated surgically and desease free) and 1 carcinoma treated with surgery and chemotherapy that ended in death due to cancer. Discussion: In our study, only 6.25% of the borderline tumors were of stage more than I, whereas other studies report a higher proportion of more advanced stages (7.5–18.5%). As borderline ovarian tumors more often arise in young women, in whom malignancy is less common and who wish to preserve their fertility, their initial surgery is often laparoscopy. Conclusions: Borderline ovarian tumors have an excellent prognosis. Good results are provided in young patients wishing to preserve fertility.
阿拉贡妇产科协会会议录(AGOA)2021年大会
Marta Lamarca Ballestero*、LeticiaÁlvarez Sarrado、Javier Navarro Sierra、Yasmina JoséGutiérrez、Isabel Negredo Quintana、Miguel Angel Ruiz Conde妇科,Miguel Servet大学医院,Paseo Isabel la Católica 1-350009,西班牙萨拉戈萨。*m.lamarca@yahoo.es目的:描述Miguel Servet大学医院17年来收治的32名绝经前患者的交界性卵巢肿瘤的临床表现、治疗和结果。方法:对2003年至2020年诊断和治疗的32例绝经前交界性卵巢肿瘤患者进行回顾性评价。结果:32例交界性肿瘤包括12例浆液性肿瘤、19例粘液性肿瘤和1例子宫内膜样肿瘤,其中2例超过I期。患者平均年龄34.5岁(14-45岁),22例有症状,疼痛是最常见的症状(68.8%)。8例主要通过腹腔镜手术,24例通过剖腹手术。与剖腹手术组相比,腹腔镜组的中位肿瘤直径较小(7.5与14.7 cm,p=0.019),手术范围较小,无子宫切除术。有21例保留生育能力的手术,7例患者尝试了后续妊娠,6例患者获得了健康孩子的妊娠(2例使用辅助生殖技术)。在7-108个月的随访时间内,有3例复发:2例交界性肿瘤(手术治疗且无病)和1例接受手术和化疗的癌症,最终因癌症死亡。讨论:在我们的研究中,只有6.25%的交界性肿瘤的分期高于I期,而其他研究报告的晚期肿瘤比例更高(7.5-18.5%)。由于交界性卵巢肿瘤更常见于年轻女性,她们的恶性肿瘤不太常见,并且希望保持生育能力,因此她们最初的手术通常是腹腔镜手术。结论:卵巢交界性肿瘤预后良好。在希望保持生育能力的年轻患者中提供了良好的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
25.00%
发文量
58
审稿时长
1 months
期刊介绍: EJGO is dedicated to publishing editorial articles in the Distinguished Expert Series and original research papers, case reports, letters to the Editor, book reviews, and newsletters. The Journal was founded in 1980 the second gynaecologic oncology hyperspecialization Journal in the world. Its aim is the diffusion of scientific, clinical and practical progress, and knowledge in female neoplastic diseases in an interdisciplinary approach among gynaecologists, oncologists, radiotherapists, surgeons, chemotherapists, pathologists, epidemiologists, and so on.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信